InMode Ltd. is a provider of medical technologies. It develops, manufactures and markets devices harnessing novel radio-frequency technology. The company serves plastic surgery, gynecology, dermatology, otolaryngology and ophthalmology. InMode Ltd. is based in Yokneam, Israel.
| Revenue (Most Recent Fiscal Year) | $394.82M |
| Net Income (Most Recent Fiscal Year) | $181.27M |
| PE Ratio (Current Year Earnings Estimate) | 8.95 |
| PE Ratio (Trailing 12 Months) | 9.29 |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 2.35 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 1.49 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 8.00 |
| Pre-Tax Margin (Trailing 12 Months) | 35.64% |
| Net Margin (Trailing 12 Months) | 44.79% |
| Return on Equity (Trailing 12 Months) | 17.17% |
| Return on Assets (Trailing 12 Months) | 15.20% |
| Current Ratio (Most Recent Fiscal Quarter) | 8.73 |
| Quick Ratio (Most Recent Fiscal Quarter) | 7.86 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | 1.34 |
| Book Value per Share (Most Recent Fiscal Quarter) | $9.80 |
| Earnings per Share (Most Recent Fiscal Quarter) | $0.26 |
| Earnings per Share (Most Recent Fiscal Year) | $1.57 |
| Diluted Earnings per Share (Trailing 12 Months) | $2.33 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 63.21M |
| Free Float | 58.84M |
| Market Capitalization | $922.22M |
| Average Volume (Last 20 Days) | 0.96M |
| Beta (Past 60 Months) | 2.02 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 6.92% |
| Percentage Held By Institutions (Latest 13F Reports) | 68.04% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |